COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • June 3rd, 2011 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 1, 2010 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”). The parties hereto agree as follows:
LICENSE AND COLLABORATION AGREEMENT between Nymox Pharmaceutical Corp. and Recordati Ireland Ltd.License and Collaboration Agreement • June 3rd, 2011 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
This License and Collaboration Agreement (hereinafter referred to as the “Agreement”) is made and entered into as of the 16th of December 2010 (the “Effective Date”) between Nymox Pharmaceutical Corp., a corporation organized and existing under the laws of Canada, with its principal business office located at 9900 Cavendish Blvd., Suite 306, St. Laurent, Quebec, Canada, H4M 2V2 (hereinafter referred to as “Nymox”), and Recordati Ireland Ltd., a limited liability company organized and existing under the laws of Ireland, with a principal business office located at Raheens East, Ringaskiddy, Co Cork, Ireland (hereinafter referred to as “Recordati”). Each of Nymox and Recordati may be referred to in this Agreement as a “Party” and together as the “Parties”.
